Acthar gel
Acthar gel is a pharmaceutical drug with 16 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
46.2%
6 of 13 finished
53.8%
7 ended early
0
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Use of CXCL9 as a Biomarker of Acthar Efficacy
ACTHar in the Treatment of Lupus Nephritis
ACTH Gel Therapy in Rheumatoid Arthritis
Acthar Gel in Participants With Pulmonary Sarcoidosis
Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar
Clinical Trials (16)
Use of CXCL9 as a Biomarker of Acthar Efficacy
ACTHar in the Treatment of Lupus Nephritis
ACTH Gel Therapy in Rheumatoid Arthritis
Acthar Gel in Participants With Pulmonary Sarcoidosis
Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar
Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
Acthar Gel for Active Systemic Lupus Erythematosus (SLE)
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses
Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population
Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Comprehensive Analysis of Relapse in Multiple Sclerosis
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16